We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+53.45%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$450M
AUM Growth
+$145M
Cap. Flow
+$28.1M
Cap. Flow %
6.24%
Top 10 Hldgs %
97.57%
Holding
15
New
2
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
NVRO
NEVRO CORP.
NVRO
+$21.6M
2
TARA icon
Protara Therapeutics
TARA
+$9.91M

Top Sells

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.44M

Sector Composition

Rank Sector Weight
1 Healthcare 28.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$227M 50.39%
5,831,253
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$45.5M 10.12%
2,413,819
– –
PETX
3
DELISTED
Aratana Therapeutics, Inc.
PETX
$37.8M 8.39%
2,118,845
– –
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$34.6M 7.68%
1,220,672
– –
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$26.6M 5.9%
+686,704
New +$21.6M
TRIV
6
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$22.3M 4.96%
1,776,692
– –
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$15.6M 3.47%
1,779
-593
-25% -$3.44M
ALT icon
8
Altimmune
ALT
$539M
$11.5M 2.55%
21,159
– –
TARA icon
9
Protara Therapeutics
TARA
$226M
$10.2M 2.27%
+24,585
New +$9.91M
HSTO
10
DELISTED
Histogen Inc. Common Stock
HSTO
$8.35M 1.85%
5,960
– –
VSTM icon
11
Verastem
VSTM
$532M
$7.46M 1.66%
68,057
– –
ETRM
12
DELISTED
EnteroMedics Inc.
ETRM
$1.58M 0.35%
1,060
– –
SVRA icon
13
Savara
SVRA
$1.13B
$1.43M 0.32%
36,455
– –
SGMO
14
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$342K 0.08%
22,487
– –
MGNX icon
15
MacroGenics
MGNX
$235M
$111K 0.02%
3,168
– –

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, MPM Asset Management held 15 positions worth $450M, up 47% from $306M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

MPM Asset Management deployed $28.1M of net new capital in Q4 2014, opening 2 new positions. Its largest new stake was NEVRO CORP.: 686,704 shares worth $26.6M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 34% a quarter earlier.

On the sell side, the largest reduction was Eiger BioPharmaceuticals, Inc., an estimated $3.44M trimmed.

  • MPM Asset Management's largest Q4 2014 buy was NEVRO CORP.: 686,704 shares worth $26.6M.
  • MPM Asset Management's biggest Q4 2014 reduction was Eiger BioPharmaceuticals, Inc., cutting an estimated $3.44M.
  • MPM Asset Management's ten largest holdings make up 98% of its $450M portfolio in Q4 2014.
  • MPM Asset Management opened 2 new positions and closed 0 in Q4 2014.
  • MPM Asset Management's portfolio value rose 47% quarter-over-quarter to $450M.

Based on MPM Asset Management's 13F filing for Q4 2014, filed 2 Feb 2015.